Skip to main content
Sarah Leary, MD, Pediatric Hematology & Oncology, Seattle, WA, Seattle Children's Hospital

SarahE.LearyMD

Pediatric Hematology & Oncology Seattle, WA

Professor of Pediatrics, University of Washington School of Medicine

Dr. Leary is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Leary's full profile

Already have an account?

Education & Training

  • University of Tennessee
    University of TennesseeFellowship, Pediatric Hematology/Oncology, 2004 - 2007
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 2001 - 2004
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 2001

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2009 - 2026
  • AK State Medical License
    AK State Medical License 2021 - 2022
  • MD State Medical License
    MD State Medical License 2007 - 2010
  • DC State Medical License
    DC State Medical License 2007 - 2010
  • VA State Medical License
    VA State Medical License 2007 - 2010
  • TN State Medical License
    TN State Medical License 2004 - 2008
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Heterogeneity Within the PF-EPN-B Ependymoma Subgroup  
    Andrew Grossbach, Vijay Ramaswamy, Benjamin Lu, Mariarita Santi, Caterina Giannini, Linda M Liau, Terri S Armstrong, Sarah Leary, Matthias A Karajannis, Kenneth Aldape..., Acta Neuropathologica

Press Mentions

  • Blaze Bioscience Announces Enrollment Is Complete on Its Pivotal Phase 2/3 Trial of Tozuleristide and the CanvasTM Imaging System in Pediatric Central Nervous System Tumors
    Blaze Bioscience Announces Enrollment Is Complete on Its Pivotal Phase 2/3 Trial of Tozuleristide and the CanvasTM Imaging System in Pediatric Central Nervous System TumorsNovember 2nd, 2022
  • New Grant Enables Further Testing of Reliable, Non-Invasive Pediatric Brain Cancer Platform
    New Grant Enables Further Testing of Reliable, Non-Invasive Pediatric Brain Cancer PlatformOctober 31st, 2022
  • Seattle Children’s Research Division: Celebrating 15 Years of Innovation
    Seattle Children’s Research Division: Celebrating 15 Years of InnovationNovember 12th, 2021
  • Join now to see all

Hospital Affiliations